Literature DB >> 7812481

A comparison of two measures of quality of life: their sensitivity and validity for patients with advanced cancer.

I J Higginson1, M McCarthy.   

Abstract

We compared two measures that have been used by professionals to assess the quality of life and care of patients with advanced cancer. The Support Team Assessment Schedule (STAS) is an instrument for palliative cancer support teams to record and evaluate their care; the Hebrew Rehabilitation Centre for the Aged Quality of Life (HRCA-QL) index was used in the National Hospice Study (USA) to assess patients with advanced cancer. STAS has 17 items, each scaled 0 (best) to 4 (worst), and HRCA-QL has five items scaled 0 (worst) to 2 (best). The STAS and the HRCA-QL were assessed contemporaneously by the members of one support team on 128 consecutive patients referred over 17 months. Seventy-four patients spent more than four weeks in care. Ratings for four out of five HRCA-QL items deteriorated significantly in the four to six weeks before death. HRCA-QL index items correlated with similar STAS items. Correlations were highest at referral, especially in patients seen more than four weeks before death (e.g. symptom control (STAS) with health (HRCA-QL) Spearman's rho = -0.64) and the HRCA-QL total was correlated with STAS subtotal of six items (rho = -0.45). There were few correlations at death. The findings support the validity of both measures for the aspects compared, but indicated that STAS was more sensitive to changes in patients in the last six weeks of life.

Entities:  

Mesh:

Year:  1994        PMID: 7812481     DOI: 10.1177/026921639400800403

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  6 in total

1.  Measuring quality of life: Using quality of life measures in the clinical setting.

Authors:  I J Higginson; A J Carr
Journal:  BMJ       Date:  2001-05-26

2.  Quality of life for oncology patients during the terminal period. Validation of the HRCA-QL index.

Authors:  Joan Llobera; Magdalena Esteva; Enric Benito; Josefa Terrasa; Juli Rifà; Onofre Pons; Ascensión Maya
Journal:  Support Care Cancer       Date:  2003-03-22       Impact factor: 3.603

3.  Application of quality audit tools to evaluate care quality received by terminal cancer patients admitted to a palliative care unit.

Authors:  Li-Yun Tsai; In-Fun Li; Ching-Ping Liu; Wen-Hao Su; Tse-Yun Change
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

Review 4.  Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment.

Authors:  M Michael; I F Tannock
Journal:  CMAJ       Date:  1998-06-30       Impact factor: 8.262

Review 5.  Quality of life: a deconstruction for clinicians.

Authors:  Michael Koller; Wilfried Lorenz
Journal:  J R Soc Med       Date:  2002-10       Impact factor: 18.000

6.  The development of the Canberra symptom scorecard: a tool to monitor the physical symptoms of patients with advanced tumours.

Authors:  Margherita J Barresi; Bruce Shadbolt; Don Byrne; Robin Stuart-Harris
Journal:  BMC Cancer       Date:  2003-12-17       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.